In Brief: Jin Bu Huan
This article was originally published in The Tan Sheet
Executive Summary
Jin Bu Huan: Public Citizen's Health Research Group warns in its February Health Letter that "if you or someone you know is taking this Chinese herbal remedy, we strongly advise against using the product and urge that professional help be sought to monitor for any possible evidence of liver damage." HRG cites a case report analysis published in the Nov. 15, 1994 Annals of Internal Medicine associating the product with hepatotoxicity in seven patients ("The Tan Sheet" Nov. 21, 1994, p. 12). HRG adds that "we are not against herbal or plant products per se," but "we think herbal drugs, like conventional ones, should be assessed scientifically for safety and effectiveness before being marketed"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning